Latest News & Updates
Breaking News
1 hour ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Zydus Secures FDA Priority Review for Saroglitazar NDA in Primary Biliary Cholangitis with November 2026 PDUFA Date
FDA grants Zydus priority review for saroglitazar NDA in PBC, setting a November 27, 2026 PDUFA date on Phase 3 EPICS-III data.
Pharma Now Editorial Team
Samsung Bioepis Launches Aflibercept Biosimilar OPUVIZ Across European Markets
Samsung Bioepis launches OPUVIZ, its aflibercept biosimilar referencing Eylea, as its fifth directly commercialized biosimilar across European markets.
Pharma Now Editorial Team
Sanofi Launches AccelRare AI Diagnostic Tool in India Following Class A Medical Device Classification
Sanofi's AccelRare receives Class A medical device classification in India, setting a regulatory reference point for AI pre-diagnostic tools in emerging markets.
Pharma Now Editorial Team
AstraZeneca Secures 11 CDSCO Approvals in FY26 as India Revenue Reaches Rs. 22.76 Billion
AstraZeneca secured 11 CDSCO approvals in FY26 as India revenue rose 33% YoY to Rs. 22.76 billion, with oncology contributing Rs. 16.1 billion.
Pharma Now Editorial Team
